Barostim and the Window of Opportunity in Class II/III HFrEF Patients HFSA Symposium 2023 Discussion
Hear discussion and insights from Drs. Dmitry Yaranov, William T. Abraham, Gurusher Panjrath, and Patrick McCann following the HFSA 2023 symposium.
Comments 0
Login to view comments.
Click here to Login
